For: | Caccaro R, Savarino E, D’Incà R, Sturniolo GC. Noninfectious interstitial lung disease during infliximab therapy: Case report and literature review. World J Gastroenterol 2013; 19(32): 5377-5380 [PMID: 23983443 DOI: 10.3748/wjg.v19.i32.5377] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i32/5377.htm |
Number | Citing Articles |
1 |
Ebru Atike Ongun, Reha Artan, Aysen Bingol, Oguz Dursun. A rare aspect of Crohn\'s disease: Pulmonary involvement in a child. Indian Journal of Critical Care Medicine 2016; 20(2): 114 doi: 10.4103/0972-5229.175941
|
2 |
Takuya Masuda, Atsushi Yoshida, Fumiaki Ueno, Shintaro Hara, Haruaki Nabeta, Shotaro Umezawa, Mayuki Shirai, Yoshihide Morikawa, Toshio Morizane, Yutaka Endo, Toshifumi Hibi. A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFα. Inflammatory Intestinal Diseases 2019; 4(1): 35 doi: 10.1159/000497778
|
3 |
Antonia Assioura, Georgia Gkrepi, Konstantinos Exarchos, Konstantinos Kostikas, Athena Gogali, Christos Kyriakopoulos. Recurrent bilateral lung infiltrates in a patient with ulcerative colitis. Breathe 2022; 18(4): 220210 doi: 10.1183/20734735.0210-2022
|
4 |
Ho-Su Lee, Kyung-Wook Jo, Tae Sun Shim, Jin Woo Song, Hyo Jeong Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim, Suk-Kyun Yang. Six Cases of Lung Injury Following Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2015; 9(11): 1053 doi: 10.1093/ecco-jcc/jjv135
|
5 |
Harbir Arora, Shailender Madani, Larisa V. Debelenko, Eric J. McGrath, Ramakrishna Mutyala, Lokesh Guglani. Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence?. The Clinical Respiratory Journal 2015; 9(4): 506 doi: 10.1111/crj.12168
|
6 |
Massimo Calderazzo, Pierandrea Rende, Paolo Gambardella, Giovambattista De Sarro, Luca Gallelli. A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment. Drug Safety - Case Reports 2015; 2(1) doi: 10.1007/s40800-015-0010-8
|
7 |
Lídia Gomes1, Maria Alcide Marques1, Pedro Gonçalo Ferreira1. Fulminant organizing pneumonia in a patient with ulcerative colitis on mesalamine and infliximab: striving to identify the cause!. Jornal Brasileiro de Pneumologia 2023; : e20220467 doi: 10.36416/1806-3756/e20220467
|
8 |
Hiroaki Iwata, Naoya Haga, Tatsuro Sugai, Yasuyuki Fujita. Serum Krebs von den Lungen‐6 levels in psoriatic patients under treatment with biologics. The Journal of Dermatology 2021; 48(3): 376 doi: 10.1111/1346-8138.15665
|
9 |
Syed Alishan Nasir, Ronak Patel, Steven Wojkiewicz, Robyn Scatena. Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC). Cureus 2022; doi: 10.7759/cureus.33064
|
10 |
|
11 |
Rymon Rofaiel, Sonny Kohli, Marco Mura, Seyed M Hosseini-Moghaddam. A 53-year-old man with dyspnoea, respiratory failure, consistent with infliximab-induced acute interstitial pneumonitis after an accelerated induction dosing schedule. BMJ Case Reports 2017; : bcr-2017-219956 doi: 10.1136/bcr-2017-219956
|
12 |
Marine Auffret, Johana Béné, Marc Lambert, Sophie Gautier. Pneumopathie interstitielle diffuse sous mésalazine : un effet indésirable sous diagnostiqué ?. Therapies 2014; 69(6): 531 doi: 10.2515/therapie/2014205
|
13 |
Satoshi Tanida, Masaya Takemura, Tsutomu Mizoshita, Keiji Ozeki, Takahito Katano, Takaya Shimura, Yoshinori Mori, Eiji Kubota, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh. Organizing Pneumonia in a Patient with Quiescent Crohn’s Disease. Case Reports in Gastrointestinal Medicine 2016; 2016: 1 doi: 10.1155/2016/8129864
|
14 |
María José Casanova, María Chaparro, Claudia Valenzuela, Carolina Cisneros, Javier P Gisbert. Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease. World Journal of Gastroenterology 2015; 21(7): 2260-2262 doi: 10.3748/wjg.v21.i7.2260
|